清热利湿活血法联合易善复治疗非酒精性脂肪性肝病的临床研究

发布时间：2018-05-25 23:02

本文选题：清热利湿活血法 + 易善复　；参考：《中华中医药学刊》2015年10期

【摘要】：目的:观察清热利湿、活血行气的中药联合易善复治疗非酒精性脂肪性肝病患者的临床疗效。方法:将120例符合诊断标准的非酒精性脂肪性肝病患者随机分为两组,每组60例,两组患者无显著差异,具有可比性。对照组给予易善复,治疗组给予口服清热利湿、活血行气的中药联合易善复进行治疗。治疗3个疗程,观察治疗前后两组患者的B超评分,肝功能酶(ALT、AST、GGT),血脂(TC、TG、HDL-C),超氧化物歧化酶,瘦素及临床疗效。结果:治疗组和对照组患者的B超评分、ALT、AST、GGT、TC、TG、瘦素显著降低,HDL-C、超氧化物歧化酶显著升高,而治疗组的各项指标改善的更显著;治疗组患者显效率显著高于对照组。结论:口服清热利湿、活血行气的中药联合易善复治疗非酒精性脂肪性肝病患者可以取得较好的疗效。
[Abstract]:Objective: to observe the clinical effect of clearing heat and promoting dampness and activating blood circulation and qi in patients with non-alcoholic fatty liver disease. Methods: 120 patients with non-alcoholic fatty liver disease who met the diagnostic criteria were randomly divided into two groups with 60 cases in each group. There was no significant difference between the two groups. The control group was given Yi Shanfu, while the treatment group was treated with traditional Chinese medicine combined with Yi Shanfu. After 3 courses of treatment, the B-ultrasound score, liver function enzyme alt, TGG, HDL-C, superoxide dismutase (SOD), leptin and clinical efficacy were observed before and after treatment. Results: the patients in the treatment group and the control group were assessed by B-mode ultrasound. The leptin significantly decreased HDL-C, the superoxide dismutase increased significantly, and the indexes of the treatment group improved more significantly, and the effective rate of the patients in the treatment group was significantly higher than that in the control group. Conclusion: the treatment of non-alcoholic fatty liver disease with traditional Chinese medicine combined with Yi Shan-Fu can obtain good curative effect in the treatment of non-alcoholic fatty liver disease by oral administration of Chinese medicine for clearing heat and promoting dampness and activating blood circulation.
【作者单位】：浙江省立同德医院;
【分类号】：R575.5

【参考文献】